Agbabiaka TB, Savović J, Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf. 2008;31(1):21–37. https://doi.org/10.2165/00002018-200831010-00003.

Article  PubMed  Google Scholar 

Khan LM, Al-Harthi SE, Osman AM, Sattar MA, Ali AS. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharm J. 2016;24(4):485–93. https://doi.org/10.1016/j.jsps.2015.01.010.

Article  PubMed  Google Scholar 

Théophile H, Arimone Y, Miremont-Salamé G, et al. Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre. Drug Saf. 2010;33(11):1045–54. https://doi.org/10.2165/11537780-000000000-00000.

Article  PubMed  Google Scholar 

Miremont G, Haramburu F, Bégaud B, Péré JC, Dangoumau J. Adverse drug reactions: physicians’ opinions versus a causality assessment method. Eur J Clin Pharmacol. 1994;46(4):285–9. https://doi.org/10.1007/BF00194392.

Article  PubMed  CAS  Google Scholar 

Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther. 2003;28(2):137–43. https://doi.org/10.1046/j.1365-2710.2003.00475.x.

Article  PubMed  CAS  Google Scholar 

Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf. 2005;14(12):885–90. https://doi.org/10.1002/pds.1138.

Article  PubMed  Google Scholar 

Doherty MJ. Algorithms for assessing the probability of an adverse drug reaction. Respir Med CME. 2009;2:63–7. https://doi.org/10.1016/j.rmedc.2009.01.004.

Article  Google Scholar 

Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45. https://doi.org/10.1038/clpt.1981.154.

Article  PubMed  CAS  Google Scholar 

Meyboom RH, Hekster YA, Egberts AC, Gribnau FW, Edwards IR. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf. 1997;17(6):374–89. https://doi.org/10.2165/00002018-199717060-00004.

Article  PubMed  CAS  Google Scholar 

Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm. 1986;43(7):1709–14.

PubMed  CAS  Google Scholar 

Kane-Gill SL, Forsberg EA, Verrico MM, Handler SM. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs. Drug Saf. 2012;35(8):645–53. https://doi.org/10.1007/BF03261961.

Article  PubMed  Google Scholar 

Macedo AF, Marques FB, Ribeiro CF. Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs? Drug Saf. 2006;29(8):697–702. https://doi.org/10.2165/00002018-200629080-00006.

Article  PubMed  Google Scholar 

Koch-Weser J, Sellers EM, Zacest R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol. 1977;11(2):75–8. https://doi.org/10.1007/BF00562895.

Article  PubMed  CAS  Google Scholar 

Arimone Y, Bégaud B, Miremont-Salamé G, et al. Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol. 2005;61(3):169–73. https://doi.org/10.1007/s00228-004-0869-2.

Article  PubMed  Google Scholar 

Arimone Y, Miremont-Salamé G, Haramburu F, et al. Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions. Br J Clin Pharmacol. 2007;64(4):482–8. https://doi.org/10.1111/j.1365-2125.2007.02937.x.

Article  PubMed  PubMed Central  Google Scholar 

Kosov M, Maximovich A, Riefler J, Dignani MC, Belotserkovskiy M, Batson E. Interexpert agreement on adverse events’ evaluation. Applied Clinical Trials Online; 2016. Available at: http://www.appliedclinicaltrialsonline.com/interexpert-agreement-adverse-events-evaluation. Accessed 21 June 2017.

Meehl PE. Clinical versus statistical prediction: a theoretical analysis and a review of the evidence. Minneapolis: University of Minnesota Press; 1954.

Book  Google Scholar 

Grove WM, Zald DH, Lebow BS, Snitz BE, Nelson C. Clinical versus mechanical prediction: a meta-analysis. Psychol Assess. 2000;12:19–30.

Article  CAS  Google Scholar 

Grove WM, Lloyd M. Meehl’s contributions to clinical versus statistical prediction. J Abnorm Psychol. 2006;115(2):192–4. https://doi.org/10.1037/0021-843X.115.2.192.

Article  PubMed  Google Scholar 

Comfort S, Dorrell D, Meireis S, Fine J. Modified NARanjo Causality Scale for ICSRs (MONARCSi): a decision support tool for safety scientists. Drug Saf. 2018;41(11):1073–85. https://doi.org/10.1007/s40264-018-0690-y.

Article  PubMed  PubMed Central  Google Scholar 

Bass I. Six sigma statistics with EXCEL and MINITAB, 1st edn. McGraw Hill Companies Inc; 2007.

Lim C, Wannapinij P, While L, Day Nicholas PJ, Cooper Ben S, Peacock Sharon J, Limmathurotsakul D. Using a web-based application to define the accuracy of diagnostic tests when the gold standard is imperfect. PLoS ONE. 2013;8(11): e79489. https://doi.org/10.1037/journal.pone.0079489.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Joseph L, Gyorkos TW, Coupal L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. Am J Epidemiol. 1995;141(3):263–72. https://doi.org/10.1093/oxfordjournals.aje.a117428.

Article  PubMed  CAS  Google Scholar 

Bolstad WM. Introduction to Bayesian statistics. 2nd ed. New York: Wiley; 2007.

Book  Google Scholar 

Viera AJ, Garrett JM. Understanding Interobserver Agreement: the kappa statistic. Fam Med. 2005;37:360–3.

PubMed  Google Scholar 

Davies EC, Rowe PH, James S, Nickless G, Ganguli A, Danjuma M, et al. An investigation of disagreement in causality assessment of adverse drug reactions. Pharm Med. 2011;25:17–24.

Article  Google Scholar 

Report of CIOMS Working Group VI. Management of safety information from Clinical Trials, 1st edn. CIOMS; 2005.